3,815.00
+3(+0.08%)
Currency In JPY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
4138
First IPO Date
January 01, 2001
| Name | Title | Pay | Year Born |
| Mr. Terukazu Kato | President, Chief Executive Officer & Chairman | 139M | 1963 |
| Mr. Koin Toda | Co-Chief Operating Officer | 0 | N/A |
| Mr. Kei Sugii | Co-Chief Operating Officer & Director | 0 | 1969 |
| Yukinori Sorata | Executive Officer & GM of Prescription Pharmaceutical Sales Division | 0 | N/A |
| Kaoru Kobayashi | Chief Financial Officer & Head of the Corporate Management Division | 0 | N/A |
| Makoto Kitamura | Head of Corporate Communications Dept. | 0 | N/A |
| Koji Endo | Executive Officer & Chief Human Resources Officer | 0 | N/A |
| Tadahiro Abe | GM of Healthcare Division & Executive Officer | 0 | N/A |
| Kouji Shiseki | Executive Officer and GM of Legal & Compliance Control Department | 0 | N/A |
| Zhang Liqing | Executive Officer | 0 | N/A |
Tsumura & Co. engages in the manufacture and sale of pharmaceutical products worldwide. The company offers Kampo extract intermediates and granular Kampo formulations. It is involved in the procurement, selection and processing, and storage of raw material crude drugs and crude drug pieces for decoction; manufacture of Kampo powdered extracts and traditional Chinese medicines; and sale of pharmaceuticals and food products. The company was founded in 1893 and is headquartered in Tokyo, Japan.
